Call-On-Doc Review
Semaglutide & tirzepatide GLP-1 weight-loss telehealth · Independently scored 6.1/10
Best for: choosing between a $75 brand-drug visit and an all-in compounded GLP-1 plan
Call-On-Doc falls below our bar on disclosure. It charges from $185 a month; its compounded semaglutide, at $250, is 26% above the $199 median among the sellers we compare.
Some of the links on this page earn us money. If you sign up with a provider after following one, that provider may pay GLP Watchdog a commission. Learn more
Covered by the monthly price
Medication
Not stated
Clinician visits
In the price
Shipping
Not stated
Lab work
Not stated
Coaching
Not stated
Prices checked October 2026
Call-On-Doc is a multi-condition telehealth service that now sells its own compounded GLP-1 programs. Compounded semaglutide with home delivery costs $250 a month and tirzepatide $375, with microdose versions at $185 and $285. A $75 care-only visit covers branded drugs such as Wegovy, Zepbound and Foundayo, which you buy at your own pharmacy with insurance or cash.
Is Call-On-Doc legit?
Yes. Call-On-Doc is a real, operating US company, and we found no FDA warning letters issued to it. We rate it 6.1/10 overall, across six areas from price to trust and safety. Legitimate is not the same as right for you, though: that part is a decision for you and a licensed clinician.
Is there a Call-On-Doc promo or coupon code?
We know of no promo or coupon code for Call-On-Doc. Its listed price is $185 a month. Coupon sites advertising "Call-On-Doc discount codes" are not a source we can vouch for, and any genuine offer shows at checkout without a code.
See how Call-On-Doc compares on our rankings of the best semaglutide providers and the best tirzepatide providers.
Vetted alternatives to Call-On-Doc
Collective
Best for: flat any-dose pricing, if you can absorb a $199 annual membership on top
Editorial score · methodology
Embody
Best for: a flat compounded tirzepatide or semaglutide price at every dose, from a seller that names its pharmacies
Editorial score · methodology
RxSpan MD
Best for: knowing which pharmacy fills the vial: it names Belmar Pharmacy
Editorial score · methodology
Call-On-Doc at a glance
- Type
- GLP-1 telehealth provider
- Starting price
- $185/mo
- What's included
- Consult
- Availability
- All 50 states
- FDA status
- No FDA warning letters found
How Call-On-Doc scores
Six columns, each one computed from something Call-On-Doc has published rather than from an opinion we formed: what it charges, which molecules it will dispense, what its record shows, and what the monthly figure actually buys. Where a seller keeps something back, such as its price or its pharmacy, the score reflects it. Every seller we review goes through the same six columns.
Value25%
3.4/10$250/month is 26% above the $199 median for compounded semaglutide across the sellers we compare. A cheaper microdose price is also listed; Value is scored on the standard dose.
Effectiveness25%
10.0/10Dispenses semaglutide and tirzepatide, including the FDA-approved product. Anchored to SURMOUNT-1 (tirzepatide, -20.9%) and STEP 1 (semaglutide, -14.9%).
User Experience15%
3.0/10No price appears until the medical intake is finished.
Trust & Safety15%
5.0/10No pharmacy is named for its prescriptions. Its price appears only after the medical intake. It lists the states it serves.
Accessibility10%
10.0/10Serves all 50 states.
Support10%
5.0/10States too little about what the monthly cost covers to score the bundle. Held at the midpoint rather than assumed.
A seller that shows no price until after the medical intake loses points on User Experience and Trust & Safety, and its review says so. How we score →
What we checked on Call-On-Doc
Last checked October 2026- Checked the listed price across 6 dose or plan tiers
- Checked state coverage: all 50
- Checked what the monthly price covers, and what it leaves out
- Checked FDA warning letters for Call-On-Doc
Price, availability, and compliance here are read off the seller's own pages and off primary regulatory records, named in the sources below.
What signing up with Call-On-Doc involves
What to expect on the way to a prescription: where the price appears, who fills the medication, and what the monthly price covers. It is not medical advice, and a clinician makes the prescribing decision.
- 1Call-On-Doc shows a price only after you finish its medical questionnaire, so you cannot compare costs until you have shared health information.
- 2Ask Call-On-Doc which pharmacy fills the prescription before you pay. The pharmacy's name is what lets you check its license.
- 3The monthly price includes clinician visits.
- Lowest ongoing monthly price: semaglutide $185, tirzepatide $285. That leaves out membership fees, first-month rates and insurance copays.
- Call-On-Doc serves all 50 states.
- The medication is compounded, so it is not an FDA-approved product and has not been reviewed by the agency for safety, effectiveness or manufacturing quality.
Contacting Call-On-Doc
- Phone
- +1 (214) 466-6618
- Hours
- 24/7 customer support; live call daily 5am CT - 3am CT
Medications Call-On-Doc lists
Call-On-Doc lists semaglutide and tirzepatide. Each one has its own guide: how it works, the dosing schedule, the side effects that show up in practice, and what the trials measured.
Pricing
Prices re-verified
Check the price yourself before you pay
Every figure here comes from Call-On-Doc's own website, as of the date shown. Sellers move prices without announcing it, and promotional rates lapse, so confirm the standing cost on their site before committing.
In its favor
- The monthly price includes clinician visits
- Serves all 50 states
- We found no FDA warning letters issued to Call-On-Doc
Against it
- Semaglutide costs $250 a month, 26% above the $199 median for compounded semaglutide across the sellers we compare
- Tirzepatide costs $375 a month, 39% above the $269 median for compounded tirzepatide across the sellers we compare
- You only see a price after finishing the medical intake, so you cannot compare costs before sharing health information
- Ask which pharmacy fills the prescription before you pay, so you can check its license
- Its compounded semaglutide and tirzepatide are not FDA-approved, so they have not been reviewed by the agency for safety, effectiveness or manufacturing quality
What Call-On-Doc charges
Call-On-Doc lists $185/month.
- Visit fee (medication billed separately; semaglutide): $75 per visit
- Visit fee (medication billed separately; tirzepatide): $75 per visit
- Compounded semaglutide (microdose): $185/month
- Compounded semaglutide: $250/month
- Compounded tirzepatide (microdose): $285/month
- Compounded tirzepatide: $375/month
For compounded semaglutide, the median across the sellers we compare is $199/month, so Call-On-Doc's $250 is a premium, and a premium has to buy something. Check what is bundled before you accept it. Across the compounded market the dearest tenth of sellers charges about three times what the cheapest tenth does; how much GLP-1 prices actually vary explains the spread.
Bodybuilding Health+ dispenses semaglutide and tirzepatide from $179/month, which makes it the fair comparison to run before you commit here.
What Call-On-Doc dispenses
Call-On-Doc prescribes semaglutide (approved as Wegovy and Ozempic) and tirzepatide (approved as Zepbound and Mounjaro). Between them these are the two best-evidenced weight-loss molecules currently on the market. You can take the approved brand pen or the cheaper compounded preparation. What separates them is review: the approved product went through it, the compounded one did not, and that is the whole of the trade. The molecule can be the one in Ozempic and Wegovy; what differs is the formulation, the concentration and the dose ladder. Call-On-Doc also lists a microdose plan, and the published evidence on GLP-1 microdosing is letters and commentary rather than trials.
Safety and disclosure
Call-On-Doc tells you that it treats patients in all 50 states. We found no FDA warning letters issued to Call-On-Doc. Because the medication is compounded, the most useful question to ask at intake is which licensed pharmacy fills the prescription. If Call-On-Doc will not tell you, treat that as a warning sign. A 503A pharmacy answers to a state board and a 503B facility to the FDA; which one fills it changes what you can check. How we weigh oversight, disclosure and price is set out in our scoring methodology.
Who should look elsewhere
- You care most about the twelve-month total, not the first bill. A flat-rate seller such as Collective will usually win that math.
It fits if
- you need access wherever you live
- you want to try routing the cost through your insurance, where coverage is decided in three steps
Our read
Call-On-Doc costs more than the middle of this market. If the extras it charges for are ones you would actually use, that is a defensible trade. If not, the same molecule is available for less. The catch is disclosure, which is why Call-On-Doc scores low on Trust & Safety: settle the pharmacy and pricing questions above before the price decides for you.
The Bottom Line
Call-On-Doc falls below our bar on disclosure. It charges from $185 a month; its compounded semaglutide, at $250, is 26% above the $199 median among the sellers we compare.
Before you pay Call-On-Doc
Starting at $185 a month. Check today's price, then start the intake.
Where Call-On-Doc is the wrong choice
No seller suits every reader, and pretending otherwise is the easiest way to sell one. On these two counts, another seller does better.
- If the standing monthly cost is what decides it, consider WellMedRx (from $49/mo).
- If you want a human checking in, not just a prescription, consider RxSpan MD.
If none of these fits, our guide to alternatives to Call-On-Doc sets more sellers in the same category beside Call-On-Doc on price, states and what the price includes.
Frequently Asked Questions
How to check Call-On-Doc yourself
- How to Verify an Online GLP-1 Pharmacy: Six Public Checks
- How to Get a GLP-1 Prescription
- How to Read a Peptide Certificate of Analysis (and What It Cannot Prove)
Every seller that ships to your state, side by side: Colorado, Nevada, New Mexico, North Carolina, Ohio, Oregon, South Carolina, Wisconsin and every other state.
Glossary
The words sellers use, defined. Tap any term.
- Semaglutide · Drugs and brands
- Tirzepatide · Drugs and brands
- Compounded GLP-1 · Pharmacy and drug forms
- 503A pharmacy · Pharmacy and drug forms
- PCAB accreditation · Pharmacy and drug forms
- Prior authorization (PA) · Insurance and regulatory
- Off-label use · Insurance and regulatory
- FDA Drug Shortage List · Insurance and regulatory
Sources
Cited across this Call-On-Doc review: primary regulatory filings, and peer-reviewed studies.
Sources & methodology — as of October 2026
- 1.GLP Watchdog — GLP-1 Pricing Index 2026 (our independent dataset)— GLP Watchdog.
- 2.FDA — Compounding and the 503A Pharmacy Framework— U.S. Food & Drug Administration.
- 3.FDA — Drug Shortages Database (current shortage listings)— U.S. Food & Drug Administration.
- 4.PCAB — Pharmacy Compounding Accreditation Board Standards— Accreditation Commission for Health Care (ACHC) / PCAB.
- 5.KFF — Medicaid coverage research (anti-obesity & GLP-1 drug policy)— Kaiser Family Foundation.
- 6.STEP 1 Trial — Once-Weekly Semaglutide in Adults with Overweight or Obesity (Wilding JPH et al.)— New England Journal of Medicine.PMID: 33567185.
- 7.FDA — Wegovy (semaglutide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 8.FDA — Ozempic (semaglutide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 9.SURMOUNT-1 Trial — Tirzepatide Once Weekly for the Treatment of Obesity (Jastreboff AM et al.)— New England Journal of Medicine.PMID: 35658024.
- 10.FDA — Zepbound (tirzepatide) Approval History via Drugs@FDA— U.S. Food & Drug Administration.
- 11.FDA — Mounjaro (tirzepatide) Prescribing Information via Drugs@FDA— U.S. Food & Drug Administration.
- 12.SURMOUNT-5 Trial — Tirzepatide vs. Semaglutide Head-to-Head in Obesity (Aronne LJ et al.)— New England Journal of Medicine.PMID: 40353578.
See Call-On-Doc's current pricing
Plans start at $185 a month. Whether you qualify is a clinician's decision, made after your intake.